Letter: Anhydrous theophylline equivalence of commercial theophylline formulations (Q53714166): Preview

Letter: Anhydrous theophylline equivalence of commercial theophylline formulations (Q53714166)
scientific article

Language:

Current Data About Letter: Anhydrous theophylline equivalence of commercial theophylline formulations

(P31)

(Q13442814)

(P248)
(P698)	4810107
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4810107

(P304)

116-118

(P248)
(P698)	4810107
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4810107

(P407)

(Q1860)

(P433)

(P248)
(P698)	4810107
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4810107

(P478)

(P248)
(P698)	4810107
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4810107

(P577)

Friday, February 1, 1974

(P248)
(P698)	4810107
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4810107

(P1433)

(Q7743550)

(P248)
(P698)	4810107
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4810107

(P1476)

"Letter: Anhydrous theophylline equivalence of commercial theophylline formulations" (language: en)

(P248)
(P698)	4810107
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4810107

(P2093)

E F Ellis

(P1545)	1

(P248)
(P698)	4810107
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4810107

E D Eddy

(P1545)	2

(P248)
(P698)	4810107
(P813)	Friday, May 18, 2018
(P854)	http://europepmc.org/abstract/MED/4810107

other details

description	scientific article

External Links

(P356)	10.1016/0091-6749(74)90073-6
(P698)	4810107